IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, giving promising advancements across numerous clinical and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA provides a safer, additional reliable alternative for therape